Effect of treatment on gametocyte carriage at day 7 and day 28, for those patients who were gametocytaemic on enrolment.

Variance component analyses of the prevalence of gametocytes in treated clinical episodes (Pfgam) according to drug period.

Cheikh Loucoubar (279995)
Bronner Goncalves (340403)
Adama Tall (81717)
Cheikh Sokhna (84117)
Jean-François Trape (81719)
Fatoumata Diène Sarr (246610)
Joseph Faye (280000)
Abdoulaye Badiane (340408)
Alioune Badara Ly (340411)
Aliou Diop (340414)
Avner Bar-Hen (49247)
Jean-François Bureau (280002)
Anavaj Sakuntabhai (50927)
Richard Paul (279997)

February 2013

Genetic – additive genetic effect; Intra – Intra-individual effect; House – House effect.</p

Density of resistant transmission stages increases with drug pressure.

Silvie Huijben (320103)
Andrew S. Bell (147262)
Derek G. Sim (320104)
Danielle Tomasello (457767)
Nicole Mideo (326660)
Troy Day (361864)
Andrew F. Read (130517)

September 2013

Gametocyte (transmission stage) dynamics (top four rows) of individual mice in mixed infections o...

Transmission advantage of selected line.

Laura C. Pollitt (326659)
Silvie Huijben (320103)
Derek G. Sim (320104)
Rahel M. Salathé (210179)
Matthew J. Jones (555280)
Andrew F. Read (130517)

April 2014

Asexual (solid lines) and gametocyte (dashed lines) density during the period of drug treatment (...

Percentage of patients (+CI) carrying gametocytes on specified days after treatment in CQ (A) and SP (B) treatment arms.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Percentage of patients (+CI) carrying gametocytes on specified days after treatment in CQ (A) and...

Gametocyte Carriage after Treatment with CQ/SP or Co-Artemether

Colin J Sutherland (18042)
Rosalynn Ord (18410)
Sam Dunyo (58256)
Musa Jawara (18412)
Christopher J Drakeley (58257)
Neal Alexander (18417)
Rosalind Coleman (18415)
Margaret Pinder (1712)
Gijs Walraven (18413)
Geoffrey A. T Targett (18418)

February 2013

Point-prevalence of gametocyte-positive thick films in both treatment groups at 7, 14, and 28 d p...

Numbers and percentages of individuals with gametocytes on day 7 post treatment.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Chloroquine or SP treatments in the same column that share the same superscript letter are not si...

Gametocyte prevalence rate on admission and gametocyte carriage rate (overall and among patients without gametocytaemia on admission).

Verena Ilona Carrara (17223)
Julien Zwang (261429)
Elizabeth A. Ashley (237173)
Ric N. Price (35538)
Kasia Stepniewska (74266)
Marion Barends (35532)
Alan Brockman (35533)
Tim Anderson (374303)
Rose McGready (17231)
Lucy Phaiphun (268325)
Stephane Proux (17227)
Michele van Vugt (315300)
Robert Hutagalung (374304)
Khin Maung Lwin (171017)
Aung Pyae Phyo (232872)
Piyanuch Preechapornkul (374305)
Mallika Imwong (151642)
Sasithon Pukrittayakamee (101751)
Pratap Singhasivanon (17235)
Nicholas J. White (35779)
François Nosten (17237)

February 2013

Gametocyte prevalence rate on admission and gametocyte carriage rate (overall and among patients ...

Gametocyte carriage.

Adoke Yeka (18017)
Valerie Lameyre (5661448)
Kibuuka Afizi (667480)
Mudangha Fredrick (667481)
Robinson Lukwago (667482)
Moses R. Kamya (229090)
Ambrose O. Talisuna (275825)

December 2014

The proportion of children in the ASAQ and AL groups with gametocytes between days 0 and 42 of th...

Scatter Plot of Individual Patient Gametocyte Densities

Karen I Barnes (35334)
David N Durrheim (48741)
Francesca Little (59851)
Amanda Jackson (59852)
Ushma Mehta (59853)
Elizabeth Allen (59854)
Sicelo S Dlamini (59855)
Joyce Tsoka (59856)
Barry Bredenkamp (59857)
D. Jotham Mthembu (59858)
Nicholas J White (6268)
Brian L Sharp (36695)

February 2013

The gametocyte densities (per microlitre) are given over time following treatment with SP (2000) ...

Geometric mean gametocyte density (+CI) after treatment in chloroquine (A) and SP treatment arms (B).

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Note the different scales on the Y-axis. Where the CI bars are absent, only 1 patient had gametoc...

Gametocyte positivity and density in first Pv (top) and Pf (bottom) infections after treatment with blood-stage antimalarials alone (placebo) or blood-stage antimalarials plus PQ (PQ).

Rahel Wampfler (464173)
Natalie E. Hofmann (818703)
Stephan Karl (46605)
Inoni Betuela (67110)
Benson Kinboro (818704)
Lina Lorry (680187)
Mariabeth Silkey (818706)
Leanne J. Robinson (137914)
Ivo Mueller (46609)
Ingrid Felger (92160)

July 2017

(A, D). Proportion of Pv and Pf gametocyte carriers among first infections b...

Clinical and parasitological failure rates at 28 days follow-up and for gametocytaemia at day 7.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Clinical and parasitological failure rates at 28 days follow-up and for gametocytaemia at day 7.<...

Enrolment characteristics and gametocyte carriage in relation to mutations in the dhfr gene.

Mayke J. A. M. Oesterholt (374720)
Michael Alifrangis (79967)
Colin J. Sutherland (257150)
Sabah A. Omar (374721)
Patrick Sawa (374722)
Christina Howitt (374723)
Louis C. Gouagna (310392)
Robert W. Sauerwein (82233)
Teun Bousema (79969)

February 2013

AUC = area under the curve; GM = geometric mean; IQR = interquartile range; Non-ACT = treatment w...

Univariate and multivariate risk factors for PCR confirmed recrudescent failures at day 42.

The WorldWide Antimalarial Resistance Network (WWARN) DP Study Group (614261)

December 2013

n) for each variable/levels of factor with number of recrudescence [n] by day 42.<s...

Pfs230 and Pfs48/45 antibody prevalence and concentration in relation to the duration of exposure to gametocytes during follow-up.

Teun Bousema (79969)
Will Roeffen (268555)
Hinta Meijerink (359381)
Harry Mwerinde (359382)
Steve Mwakalinga (359383)
Geert-Jan van Gemert (250563)
Marga van de Vegte-Bolmer (359384)
Frank Mosha (79968)
Geoffrey Targett (84122)
Eleanor M. Riley (25407)
Robert Sauerwein (74733)
Chris Drakeley (79962)

February 2013

Antibody concentration (optical density, OD, in the ELISA) was adjusted for background reactivity...

Variance component analyses of the prevalence of gametocytes in treated clinical episodes (Pfgam) according to drug period.

Cheikh Loucoubar (279995)
Bronner Goncalves (340403)
Adama Tall (81717)
Cheikh Sokhna (84117)
Jean-François Trape (81719)
Fatoumata Diène Sarr (246610)
Joseph Faye (280000)
Abdoulaye Badiane (340408)
Alioune Badara Ly (340411)
Aliou Diop (340414)
Avner Bar-Hen (49247)
Jean-François Bureau (280002)
Anavaj Sakuntabhai (50927)
Richard Paul (279997)

February 2013

Genetic – additive genetic effect; Intra – Intra-individual effect; House – House effect.</p

Density of resistant transmission stages increases with drug pressure.

Silvie Huijben (320103)
Andrew S. Bell (147262)
Derek G. Sim (320104)
Danielle Tomasello (457767)
Nicole Mideo (326660)
Troy Day (361864)
Andrew F. Read (130517)

September 2013

Gametocyte (transmission stage) dynamics (top four rows) of individual mice in mixed infections o...

Transmission advantage of selected line.

Laura C. Pollitt (326659)
Silvie Huijben (320103)
Derek G. Sim (320104)
Rahel M. Salathé (210179)
Matthew J. Jones (555280)
Andrew F. Read (130517)

April 2014

Asexual (solid lines) and gametocyte (dashed lines) density during the period of drug treatment (...

Percentage of patients (+CI) carrying gametocytes on specified days after treatment in CQ (A) and SP (B) treatment arms.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Percentage of patients (+CI) carrying gametocytes on specified days after treatment in CQ (A) and...

Gametocyte Carriage after Treatment with CQ/SP or Co-Artemether

Colin J Sutherland (18042)
Rosalynn Ord (18410)
Sam Dunyo (58256)
Musa Jawara (18412)
Christopher J Drakeley (58257)
Neal Alexander (18417)
Rosalind Coleman (18415)
Margaret Pinder (1712)
Gijs Walraven (18413)
Geoffrey A. T Targett (18418)

February 2013

Point-prevalence of gametocyte-positive thick films in both treatment groups at 7, 14, and 28 d p...

Numbers and percentages of individuals with gametocytes on day 7 post treatment.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Chloroquine or SP treatments in the same column that share the same superscript letter are not si...

Gametocyte prevalence rate on admission and gametocyte carriage rate (overall and among patients without gametocytaemia on admission).

Verena Ilona Carrara (17223)
Julien Zwang (261429)
Elizabeth A. Ashley (237173)
Ric N. Price (35538)
Kasia Stepniewska (74266)
Marion Barends (35532)
Alan Brockman (35533)
Tim Anderson (374303)
Rose McGready (17231)
Lucy Phaiphun (268325)
Stephane Proux (17227)
Michele van Vugt (315300)
Robert Hutagalung (374304)
Khin Maung Lwin (171017)
Aung Pyae Phyo (232872)
Piyanuch Preechapornkul (374305)
Mallika Imwong (151642)
Sasithon Pukrittayakamee (101751)
Pratap Singhasivanon (17235)
Nicholas J. White (35779)
François Nosten (17237)

February 2013

Gametocyte prevalence rate on admission and gametocyte carriage rate (overall and among patients ...

Gametocyte carriage.

Adoke Yeka (18017)
Valerie Lameyre (5661448)
Kibuuka Afizi (667480)
Mudangha Fredrick (667481)
Robinson Lukwago (667482)
Moses R. Kamya (229090)
Ambrose O. Talisuna (275825)

December 2014

The proportion of children in the ASAQ and AL groups with gametocytes between days 0 and 42 of th...

Scatter Plot of Individual Patient Gametocyte Densities

Karen I Barnes (35334)
David N Durrheim (48741)
Francesca Little (59851)
Amanda Jackson (59852)
Ushma Mehta (59853)
Elizabeth Allen (59854)
Sicelo S Dlamini (59855)
Joyce Tsoka (59856)
Barry Bredenkamp (59857)
D. Jotham Mthembu (59858)
Nicholas J White (6268)
Brian L Sharp (36695)

February 2013

The gametocyte densities (per microlitre) are given over time following treatment with SP (2000) ...

Geometric mean gametocyte density (+CI) after treatment in chloroquine (A) and SP treatment arms (B).

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Note the different scales on the Y-axis. Where the CI bars are absent, only 1 patient had gametoc...

Gametocyte positivity and density in first Pv (top) and Pf (bottom) infections after treatment with blood-stage antimalarials alone (placebo) or blood-stage antimalarials plus PQ (PQ).

Rahel Wampfler (464173)
Natalie E. Hofmann (818703)
Stephan Karl (46605)
Inoni Betuela (67110)
Benson Kinboro (818704)
Lina Lorry (680187)
Mariabeth Silkey (818706)
Leanne J. Robinson (137914)
Ivo Mueller (46609)
Ingrid Felger (92160)

July 2017

(A, D). Proportion of Pv and Pf gametocyte carriers among first infections b...

Clinical and parasitological failure rates at 28 days follow-up and for gametocytaemia at day 7.

Kate Kolaczinski (185768)
Toby Leslie (185771)
Iftikhar Ali (185774)
Naeem Durrani (185777)
Sue Lee (185780)
Marion Barends (35532)
Khalid Beshir (185782)
Rosalynn Ord (18410)
Rachel Hallett (18411)
Mark Rowland (185783)

January 2012

Clinical and parasitological failure rates at 28 days follow-up and for gametocytaemia at day 7.<...

Enrolment characteristics and gametocyte carriage in relation to mutations in the dhfr gene.

Mayke J. A. M. Oesterholt (374720)
Michael Alifrangis (79967)
Colin J. Sutherland (257150)
Sabah A. Omar (374721)
Patrick Sawa (374722)
Christina Howitt (374723)
Louis C. Gouagna (310392)
Robert W. Sauerwein (82233)
Teun Bousema (79969)

February 2013

AUC = area under the curve; GM = geometric mean; IQR = interquartile range; Non-ACT = treatment w...

Univariate and multivariate risk factors for PCR confirmed recrudescent failures at day 42.

The WorldWide Antimalarial Resistance Network (WWARN) DP Study Group (614261)

December 2013

n) for each variable/levels of factor with number of recrudescence [n] by day 42.<s...

Pfs230 and Pfs48/45 antibody prevalence and concentration in relation to the duration of exposure to gametocytes during follow-up.

Teun Bousema (79969)
Will Roeffen (268555)
Hinta Meijerink (359381)
Harry Mwerinde (359382)
Steve Mwakalinga (359383)
Geert-Jan van Gemert (250563)
Marga van de Vegte-Bolmer (359384)
Frank Mosha (79968)
Geoffrey Targett (84122)
Eleanor M. Riley (25407)
Robert Sauerwein (74733)
Chris Drakeley (79962)

February 2013

Antibody concentration (optical density, OD, in the ELISA) was adjusted for background reactivity...

Variance component analyses of the prevalence of gametocytes in treated clinical episodes (Pfgam) according to drug period.

Cheikh Loucoubar (279995)
Bronner Goncalves (340403)
Adama Tall (81717)
Cheikh Sokhna (84117)
Jean-François Trape (81719)
Fatoumata Diène Sarr (246610)
Joseph Faye (280000)
Abdoulaye Badiane (340408)
Alioune Badara Ly (340411)
Aliou Diop (340414)
Avner Bar-Hen (49247)
Jean-François Bureau (280002)
Anavaj Sakuntabhai (50927)
Richard Paul (279997)

February 2013

Genetic – additive genetic effect; Intra – Intra-individual effect; House – House effect.</p

Density of resistant transmission stages increases with drug pressure.

Silvie Huijben (320103)
Andrew S. Bell (147262)
Derek G. Sim (320104)
Danielle Tomasello (457767)
Nicole Mideo (326660)
Troy Day (361864)
Andrew F. Read (130517)

September 2013

Gametocyte (transmission stage) dynamics (top four rows) of individual mice in mixed infections o...

Transmission advantage of selected line.

Laura C. Pollitt (326659)
Silvie Huijben (320103)
Derek G. Sim (320104)
Rahel M. Salathé (210179)
Matthew J. Jones (555280)
Andrew F. Read (130517)

April 2014

Asexual (solid lines) and gametocyte (dashed lines) density during the period of drug treatment (...

Effect of treatment on gametocyte carriage at day 7 and day 28, for those patients who were gametocytaemic on enrolment.

Abstract

Extracted data

Effect of treatment on gametocyte carriage at day 7 and day 28, for those patients who were gametocytaemic on enrolment.

Abstract

Extracted data

Related items

Related items